Literature DB >> 15957830

[Application of Danshen injection on early stage of renal transplantation].

Xiao-hui Tian1, Wu-jun Xue, Xiao-ming Ding.   

Abstract

OBJECTIVE: To investigate the effect of Danshen injection (DSI) on early stage of renal transplantation.
METHODS: One hundred and twelve patients in early stage after renal transplantation were allocated in the treated group, they were treated by conventional treatment with DSI 60 ml given additionally once a day for 10 days. And 109 patients who received conventional treatment alone after renal transplantation at the corresponding period were allocated in the control group. Indexes in the two groups, including volume of urine, serum creatinine (SCr), endogenous creatinine clearance rate, incidence of delayed graft function and acute rejection reaction, blood viscosity (BV), platelet aggregation rate (PAR) as well as the blood flow resistance in graft measured by color Doppler ultrasonography.
RESULTS: The urinary volume and endogenous creatinine clearance rate in the treated group were significantly higher, but levels of SCr, incidence of renal function recovery retardation, BV, PAR and blood flow resistance in graft were significantly lower than those in the control group (P < 0.05). The difference of incidence of acute rejection reaction between the two groups was insignificant (P > 0.05).
CONCLUSION: DSI can improve blood microcirculation, decrease the incidence of renal function recovery retardation, these effects are helpful for recovery of renal function after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15957830

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  7 in total

1.  Salvianolic acid B protects against doxorubicin induced cardiac dysfunction via inhibition of ER stress mediated cardiomyocyte apoptosis.

Authors:  Rongchang Chen; Guibo Sun; Longpo Yang; Jian Wang; Xiaobo Sun
Journal:  Toxicol Res (Camb)       Date:  2016-06-06       Impact factor: 3.524

2.  Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-α levels, and IL-10 mRNA, TNF-α mRNA expression levels, cerebral TGF-β1 positive expression level and its neuroprotective mechanisms in CIR rats.

Authors:  Xue-Yun Liang; Hai-Ning Li; Xiao-Yan Yang; Wen-Yan Zhou; Jian-Guo Niu; Ben-Dong Chen
Journal:  Mol Biol Rep       Date:  2013-02-02       Impact factor: 2.316

3.  Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice.

Authors:  Ying Zhang; Hao Wang; Lijing Cui; Yuanyuan Zhang; Yang Liu; Xi Chu; Zhenyi Liu; Jianping Zhang; Li Chu
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 4.  Efficacy and Safety of Salvia miltiorrhiza for Treating Chronic Kidney Diseases: A Systematic Review and Meta-Analysis.

Authors:  Wei Zhang; Jun Li; Pan Yang; Gaoqiang Wang; Yanli Yue; Yuanfang Zhong; Hanyin Liu; Dingkun Gui; Youhua Xu; Niansong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-14       Impact factor: 2.650

5.  A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.

Authors:  Xiuxiu Li; Xue Xu; Jinan Wang; Hua Yu; Xia Wang; Hongjun Yang; Haiyu Xu; Shihuan Tang; Yan Li; Ling Yang; Luqi Huang; Yonghua Wang; Shengli Yang
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

Review 6.  Synergism of Chinese Herbal Medicine: Illustrated by Danshen Compound.

Authors:  Xuefeng Su; Zhuoting Yao; Shengting Li; He Sun
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-13       Impact factor: 2.629

7.  Separation of Five Flavonoids from Aerial Parts of Salvia Miltiorrhiza Bunge Using HSCCC and Their Antioxidant Activities.

Authors:  Fan Yang; Yingxue Qi; Wei Liu; Jia Li; Daijie Wang; Lei Fang; Yongqing Zhang
Journal:  Molecules       Date:  2019-09-23       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.